CLINICAL TRIALS PROFILE FOR TESETAXEL
✉ Email this page to a colleague
Clinical Trials for Tesetaxel
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT01064713 ↗ | Phase II Study of Tesetaxel in Metastatic Melanoma | Completed | Genta Incorporated | Phase 2 | The goal of this clinical research study is to learn if tesetaxel can help to control metastatic melanoma. The safety of this drug will also be studied. |
NCT01064713 ↗ | Phase II Study of Tesetaxel in Metastatic Melanoma | Completed | M.D. Anderson Cancer Center | Phase 2 | The goal of this clinical research study is to learn if tesetaxel can help to control metastatic melanoma. The safety of this drug will also be studied. |
NCT01092585 ↗ | Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH | Unknown status | Genta Incorporated | Phase 2 | Tesetaxel is an orally administered chemotherapy agent of the taxane class. This study is being undertaken to evaluate the efficacy and safety of tesetaxel administered as second-line therapy to patients with advanced melanoma and normal serum lactate dehydrogenase (LDH). |
NCT01095120 ↗ | Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer | Unknown status | Genta Incorporated | Phase 2 | Tesetaxel is an orally administered chemotherapy agent of the taxane class. This study is being undertaken to evaluate the efficacy and safety of tesetaxel administered as second-line therapy to patients with advanced gastric cancer. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Tesetaxel
Condition Name
Clinical Trial Locations for Tesetaxel
Trials by Country
Clinical Trial Progress for Tesetaxel
Clinical Trial Phase
Clinical Trial Sponsors for Tesetaxel
Sponsor Name